Predictive value of individual serum neurofilament light chain levels in short-term disease activity in relapsing multiple sclerosis

被引:3
|
作者
Solis-Tarazona, Luis [1 ]
Raket, Lars Lau [2 ]
Cabello-Murgui, Javier [1 ]
Reddam, Salma [1 ]
Navarro-Quevedo, Silvia [3 ]
Gil-Perotin, Sara [1 ,4 ,5 ]
机构
[1] Inst Invest Sanitaria La Fe, Res Grp Immunotherapy & Biomodels Autoimmun, Valencia, Spain
[2] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden
[3] Hosp Univ & Politecn La Fe, Neurol, Valencia, Spain
[4] Hosp Univ & Politecn La Fe, Multiple Sclerosis Unit, Neurol, Valencia, Spain
[5] Inst Salud Carlos III, Consorcio Ctr Invest Biomed Red CIBER, CB06-05-1131, Madrid, Spain
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
multiple sclerosis; biomarker; relapse; Z-score; RMS; CEREBROSPINAL-FLUID; DISABILITY;
D O I
10.3389/fneur.2024.1354431
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background The assessment of serum neurofilament light chain (sNFL) has emerged as a diagnostic and prognostic tool in monitoring multiple sclerosis (MS). However, the application of periodic measurement in daily practice remains unclear.Objective To evaluate the predictive value of individual sNFL levels in determining disease activity in patients with relapsing MS (RMS).Methods In this two-year prospective study, 129 RMS patients underwent quarterly sNFL assessments and annual MRI scans. The study analyzed the correlation between individual NFL levels and past, current, and future disease activity. Group-level Z-scores were employed as a comparative measure.Results Among the 37 participants, a total of 61 episodes of disease activity were observed. sNFL levels proved valuable in distinct ways; they were confirmatory of previous and current clinical and/or radiological activity and demonstrated a high negative predictive value for future 90 days activity. Interestingly, Z-scores marginally outperformed sNFL levels in terms of predictive accuracy, indicating the potential for alternative approaches in disease activity assessment. In our cohort, sNFL cut-offs of 10.8 pg./mL (sensitivity 27%, specificity 90%) and 14.3 pg./mL (sensitivity 15%, specificity 95%) correctly identified 7 and 4 out of 26 cases of radiological activity within 90 days, respectively, with 14 and 15% false negatives. When using lower cut-off values, individuals with sNFL levels below 5 pg/mL (with a sensitivity of 92%, specificity of 25%, and negative predictive value of 94%) were less likely to experience radiological activity within the next 3 months.Conclusion Individual sNFL levels may potentially confirm prior or current disease activity and predict short-term future radiological activity in RMS. These findings underscore its periodic measurement as a valuable tool in RMS management and decision-making, enhancing the precision of clinical evaluation in routine practice.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis
    Chitnis, Tanuja
    Gonzalez, Cindy
    Healy, Brian C.
    Saxena, Shrishti
    Rosso, Mattia
    Barro, Christian
    Michalak, Zuzanna
    Paul, Anu
    Kivisakk, Pia
    Diaz-Cruz, Camilo
    Sattarnezhad, Neda
    Pierre, Isabelle V.
    Glanz, Bonnie I.
    Tomic, Davorka
    Kropshofer, Harald
    Haring, Dieter
    Leppert, David
    Kappos, Ludwig
    Bakshi, Rohit
    Weiner, Howard L.
    Kuhle, Jens
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (12): : 1478 - 1491
  • [42] Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
    Davies, Jennifer C.
    Dharmadasa, Thanuja
    Thompson, Alexander G.
    Edmond, Evan C.
    Yoganathan, Katie
    Gao, Jiali
    Talbot, Kevin
    Turner, Martin R.
    BRAIN COMMUNICATIONS, 2023, 5 (03)
  • [43] Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
    Verde, Federico
    Milone, Ilaria
    Colombo, Eleonora
    Maranzano, Alessio
    Solca, Federica
    Torre, Silvia
    Doretti, Alberto
    Gentile, Francesco
    Manini, Arianna
    Bonetti, Ruggero
    Peverelli, Silvia
    Messina, Stefano
    Maderna, Luca
    Morelli, Claudia
    Poletti, Barbara
    Ratti, Antonia
    Silani, Vincenzo
    Ticozzi, Nicola
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [44] Neurofilament light chain predicts disease activity in relapsing-remitting MS
    Varhaug, Kristin N.
    Barro, Christian
    Bjornevik, Kjetil
    Myhr, Kjell-Morten
    Torkildsen, Oivind
    Wergeland, Stig
    Bindoff, Laurence A.
    Kuhle, Jens
    Vedeler, Christian
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2018, 5 (01):
  • [45] Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
    Hakansson, Irene
    Tisell, Anders
    Cassel, Petra
    Blennow, Kaj
    Zetterberg, Henrik
    Lundberg, Peter
    Dahle, Charlotte
    Vrethem, Magnus
    Ernerudh, Jan
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [46] Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis
    Hyun, Jae-Won
    Kim, Yeseul
    Kim, Gayoung
    Kim, Su-Hyun
    Kim, Ho Jin
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (06) : 659 - 667
  • [47] Functional and Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels
    Polunosika, Elina
    Simren, Joel
    Akmene, Arta
    Klimovskis, Nikita
    Blennow, Kaj
    Pastare, Daina
    Zetterberg, Henrik
    Erts, Renars
    Karelis, Guntis
    MEDICINA-LITHUANIA, 2025, 61 (01):
  • [48] Cerebrospinal fluid neurofilament light chain in acute optic neuritis and its predictive ability of multiple sclerosis
    Passali, Moschoula
    Galea, Ian
    Knudsen, Maria Hojberg
    Lau, Laurie Chi
    Cramer, Stig Praestekjaer
    Frederiksen, Jette Lautrup
    JOURNAL OF NEUROLOGY, 2024, : 6127 - 6135
  • [49] Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study
    Kizilay, Tugce
    Akbayir, Ece
    Erol, Ruziye
    Demir, Ayca Simay
    Yasargun, Duygu Ozkan
    Yilmaz, Vuslat
    Tuzun, Erdem
    Turkoglu, Recai
    EUROPEAN NEUROLOGY, 2024, 87 (04) : 203 - 210
  • [50] Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice
    Valentino, Paola
    Marnetto, Fabiana
    Martire, Serena
    Malucchi, Simona
    Bava, Cecilia Irene
    Popovic, Maja
    Bertolotto, Antonio
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 54